To evaluate whether the detection of Toxoplasma gondii DNA in CSF could contribute to the differential diagnosis of AIDS-related focal brain lesions, CSF samples from 88 HIV-infected patients (56 with focal brain lesions and 32 without) were tested prospectively by a nested PCR for the B1 gene of T. gondii. The assay had a detection limit of 10 trophozoite equivalents. Six of 18 patients with toxoplasmic encephalitis, but none of the 70 patients with other disorders, were PCR-positive (33.3% sensitivity and 100% specificity). Considering only those patients with cerebral toxoplasmosis from whom CSF was collected before or during the first week of antitoxoplasmic therapy, sensitivity rose to 50%. This was higher than the sensitivity in patients whose CSF was collected after the first week of treatment (odds ratio (OR) of 7.0; 95% CI: 0.46-218.2). The administration of antitoxoplasmic prophylaxis did not affect the PCR results. Patients with a poor response to therapy had a higher probability of detectable T. gondii DNA in their CSF (OR of 5.0; 95% CI: 0.37-86.6). All patients with other central nervous system disorders were PCR-negative. Despite the moderate sensitivity, the high specificity and positive predictive value (100%) make this assay a useful tool in the differential diagnosis of AIDS-related focal brain lesions as part of a series of CSF and neuroradiological examinations.
BacellarH.,
MunozA.,
MillerE. N. Temporal trends in the incidence of HIV-1-related neurologic diseases. Multicenter AIDS cohort study, 1985-1992. Neurology1994; 44:1892–1900
Centers for Disease Control 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep1992; 41:(RR17)1–19
GirardP.-M.,
LandmanR.,
GaudeboutC. Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. N Engl J Med1993; 328:1514–1520
AntinoriA.,
MurriR.,
AmmassariA. Aerosolized pentamidine, cotrimoxazole and dapsone-pyrimethamine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis. AIDS1995; 9:1343–1350
GroverC. M.,
ThulliezP.,
RemingtonJ. S.,
BoothroydJ. C. Rapid prenatal diagnosis of congenital toxoplasma infection by using polymerase chain reaction and amniotic fluid. J Clin Microbiol1990; 28:2297–2301
WeissL. M.,
UdemS. A.,
SalgoM.,
TanowitzH. B.,
WittnerM. Sensitive and specific detection of toxoplasma DNA in an experimental murine model: use of T. gonJ/7-specific cDNA and the polymerase chain reaction. J Infect Dis1991; 163:180–186
BretagneS.,
CostaJ.-M.,
Fleury-FeithJ.,
PoronF.,
Dubreuil-LemaireM.-L.,
VidaudM. Quantitative competitive PCR with bronchoalveolar lavage fluid for diagnosis of toxoplasmosis in AIDS patients. J Clin Microbiol1995; 33:1662–1664
VerhofstedeC.,
ReniersS.,
ColebundersR.,
van WanzeeleF.,
PlumJ. Polymerase chain reaction in the diagnosis of Toxoplasma encephalitis. AIDS1993; 7:1539–1541
Schoondermark-van de VenE.,
GalamaJ.,
KraaijeveldC.,
van DrutenJ.,
MeuwissenJ.,
MelchersW. Value of polymerase chain reaction for the detection of Toxoplasma gondii in cerebrospinal fluid from patients with AIDS. Clin Infect Dis1993; 16:661–666
NovatiR.,
CastagnaA.,
MorsicaG. Polymerase chain reaction for Toxoplasma gondii DNA in cerebrospinal fluid of AIDS patients with focal brain lesions. AIDS1994; 8:1691–1694
DuponM.,
CazenaveJ.,
PellegrinJ. –L. Detection of Toxoplasma gondii by PCR and tissue culture in cerebrospinal fluid and blood of human immunodeficiency virus-seropositive patients. J Clin Microbiol1995; 33:2421–2426
EggersC.,
GrossU.,
KlinkerH.,
SchalkeB.,
StellbrinkH. J.,
KunzeK. Limited value of ■ cerebrospinal fluid for direct detection of Toxoplasma gondii in toxoplasmic encephalitis associated with AIDS. J Neurol1994; 242:644–649
De LucaA.,
CingolaniA.,
LinzaloneA. Improved detection of JC virus DNA in cerebrospinal fluid for the diagnosis of AIDS-related progressive multifocal leukoencephalopathy. J Clin Microbiol1996; 34:1343–1346
De LucaA.,
AntinoriA.,
CingolaniA. Evaluation of cerebrospinal fluid EBV-DNA and IL-10 as markers for in vivo diagnosis of AIDS-related primary central nervous system lymphoma. Br J Haematol1995; 90:844–849
LebechM.,
LebechA.-M.,
NelsingS.,
VuustJ.,
MathiesenL.,
PetersenE. Detection of Toxoplasma gondii DNA by polymerase chain reaction in cerebrospinal fluid from AIDS patients with cerebral toxoplasmosis. J Infect Dis1992; 165:982–983
SackettD. L.,
HaynesR. B.,
GuyattG. H.,
TugwellP. The interpretation of diagnostic data. In: Clinical epidemiology. A basic science for clinical medicine. 2nd edn Boston: Little Brown and Company; 199169–152
AmmassariA.,
MurriR.,
CingolaniA.,
De LucaA.,
AntinoriA. AIDS-associated cerebral toxoplasmosis: an update on diagnosis and treatment. Curr Top Microbiol Immunol1996 (in press)
MathewsC.,
BarbaD.,
FullertonS. C. Early biopsy versus empiric treatment with delayed biopsy of non-responders in suspected HIV-associated cerebral toxoplasmosis: a decision analysis. AIDS1995; 9:1243–1250
ForsythP. A.,
YahalomJ.,
DeAngelisL. M. Combined-modality therapy in the treatment of primary central nervous system lymphoma in AIDS. Neurology1994; 44:1473–1479
PierceM. A.,
JohnsonM. D.,
MaciunasR. J. Evaluating contrast-enhancing brain lesions in patients with AIDS by using positron emission tomography. Ann Intern Med1995; 123:594–598